Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum

Abstract

The majority of patients improved with ustekinumab. Although no biomarker was discovered, low LTA4H concentrations with mild disease severity may be predictive of the effectiveness of ustekinumab.